News

The FDA has reopened a public docket to receive information and comments about LASIK devices, it was reported in the Nov. 13 Federal Register. The agency will accept remarks until Nov. 15, 2010.

The Centers for Medicare and Medicaid Services has stopped recognizing code Q2024 to pay for the office-based ophthalmic use of bevacizumab (Avastin, Genentech).

An investigational telescope implant has been given an 8-0 approvable vote by the FDA advisory panel.

As attendees gather for the Wilmer Eye Institute's 22nd annual Current Concepts in Ophthalmology meeting, they can expect the agenda to focus on clinical use and medical issues important to ophthalmology.

The retail optical industry is down 2.5% in 2009, according to industry published data.

If you don't know the question you want to ask, you can't ask the question to get the information you need to stay out of trouble.

When performing cataract surgery, it is critical to understand the properties of ophthalmic and viscosurgical devices.

A key role of ARVO in the eye and vision research community is to recognize excellence.

To a busy ophthalmologist, time is a valuable commodity, and with proposed Mediare cuts looming, it is a daily focus and concern.

An intraoperative wavefront aberrometer seems to be highly beneficial for patients and surgeons because it allows the surgeon to manage astigmatism effectively.

Combination therapy of an anti-platelet-derived growth factor aptamer plus an anti-vascular endothelial lesion regression in 91% of eyes with choroidal neovascularization compared with only 16% of eyes with anti-VEGF monotherapy.

A newly upgraded spectral-domain, optical coherence tomography (OCT) device with a non-mydriatic, color fundus camera enables clinicians to detect retinal abnormalities often missed during routine patient exams.

Making phone calls to remind patients about upcoming appointments may become a thing of the past.

There has been a new development in the way Current Procedural Terminology (CPT) Category III codes, also known as T-codes, are viewed, reimbursed, and treated in the means of medical billing and coding.

My friends in practice tell me that the starting pay packages being offered to ophthalmologists right out of training are becoming more modest.

Visual performance is degraded by several optical phenomena including wavefront aberrations, light scattering, and diffraction.

Ophthalmic surgical instrument manufacturers and distributors work in a constantly evolving and increasingly global marketplace, and in late 2009, are meeting challenges posed by new procedures and changing government regulations.

Although heuristic factors will always be a part of the art of ophthalmomology, we are now in an era in which payments for medical treatments are going to be increasingly scrutinized for therapeutic effectiveness.

The Centers for Medicare and Medicaid Services (CMS) reversed a reimbursement decision that would have forced clinicians to switch treatment for patients with wet age-related macular degeneration from bevacizumab to ranibizumab.

Carl Zeiss Meditec introduced its new suite of treatment workflow and data management systems at the annual meeting of the American Academy of Ophthalmology.

Lumenis Ltd. introduced an ophthalmic laser delivery technology and slit lamp biomicroscope system (InSight) at the recent annual meeting of the American Academy of Ophthalmology.

IRIDEX Corp. launched a dual-port ophthalmic green laser photocoagulator (IQ 532) and a modular multi-wavelength laser photocoagulator at the recent annual meeting of the American Academy of Ophthalmology.

Topcon Medical Systems Inc. introduced a new image management and sharing software suite (EyeRoute) at the recent American Academy of Ophthalmology annual meeting.

Ellex Medical Lasers Ltd. unveiled the latest version of its diagnostic ultrasound system (Eye Cubed) at the recent annual meeting of the American Academy of Ophthalmology.

A major gift from an Omaha, NE, ophthalmologist will help fund construction of an eye institute at the University of Nebraska Medical Center (UNMC).

MacuSight has received fast-track designation from the FDA for its proprietary ocular sirolimus (Perceiva) product for the treatment of diabetic macular edema.

Abbott Laboratories has completed its acquisition of privately held eye-care company Visiogen, adding to its vision-care business an accommodating IOL technology (Synchrony) designed to address presbyopia in patients with cataracts.

The U.S. District Court for the District of Delaware has ruled in favor of Allergan Inc. in its patent infringement lawsuit against two sets of defendants seeking to market purported generic versions of the company?s formulations of brimonidine tartrate 0.1% and 0.15% (Alphagan P) for ocular hypertension and glaucoma. Specifically, the court ruled that Allergan's five patents related to the ophthalmic solutions are valid and enforceable.